BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20058049)

  • 1. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
    Mitsuya K; Nakasu Y; Horiguchi S; Harada H; Nishimura T; Bando E; Okawa H; Furukawa Y; Hirai T; Endo M
    J Neurooncol; 2010 Aug; 99(1):81-8. PubMed ID: 20058049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
    Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
    Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Barajas RF; Chang JS; Sneed PK; Segal MR; McDermott MW; Cha S
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):367-72. PubMed ID: 19022867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.
    Hoefnagels FW; Lagerwaard FJ; Sanchez E; Haasbeek CJ; Knol DL; Slotman BJ; Vandertop WP
    J Neurol; 2009 Jun; 256(6):878-87. PubMed ID: 19274425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of Lesions after Stereotactic Radiosurgery for Brain Metastases: Impact of Delayed Contrast Magnetic Resonance Imaging.
    Wagner S; Gufler H; Eichner G; Lanfermann H
    Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):143-150. PubMed ID: 27777145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
    Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
    Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical model-based parameters to classify tumor recurrence from radiation-induced necrosis for brain metastases.
    Narasimhan S; Johnson HB; Nickles TM; Miga MI; Rana N; Attia A; Weis JA
    Med Phys; 2019 May; 46(5):2487-2496. PubMed ID: 30816555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-stereotactic radiosurgery brain metastases: a review.
    Fabiano AJ; Qiu J
    J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial MR imaging of intracranial metastases after radiosurgery.
    Hawighorst H; Essig M; Debus J; Knopp MV; Engenhart-Cabilic R; Schönberg SO; Brix G; Zuna I; van Kaick G
    Magn Reson Imaging; 1997; 15(10):1121-32. PubMed ID: 9408133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.
    Kano H; Kondziolka D; Lobato-Polo J; Zorro O; Flickinger JC; Lunsford LD
    Neurosurgery; 2010 Mar; 66(3):486-91; discussion 491-2. PubMed ID: 20173543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
    Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
    Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.